MacKenzie Realty Capital, Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-12-31; filed 2026-02-17.
0001140361-26-005766
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-15.
0001140361-26-021627
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 6 previous paragraphs and 6 current paragraphs.
5 unchanged; 1 reworded; 0 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 4 previous and 4 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to our risk factors discussed in “Risk Factors” in our annual report Form 10-K for the year ended June 30, 2025.
Reworded paragraphs (1)
Previous wording
During the six months ended December 31, 2025, we issued 4,383.78 shares of Series A preferred stock with total gross proceeds of $98,635, 7,863.09 shares of Series B preferred stock with total gross proceeds of $193,061 and 42,960 shares of Series C preferred stock with total gross proceeds of $1,074,000. We also issued 4,429.61 shares of Series A preferred stock with total gross proceeds of $99,667 under the preferred stock DRIP and 593.67 shares of Series B preferred stock with total gross proceeds of $13,358 under the preferred stock DRIP. All such issuances were pursuant to our Regulation A Series A, Series B and Series C preferred stock offering.
Current wording
During the nine months ended March 31, 2026, we issued 37,374.89 shares of Series A preferred stock with total gross proceeds of $840,935, 13,440.15 shares of Series B preferred stock with total gross proceeds of $329,411 and 52,640 shares of Series C preferred stock with total gross proceeds of $1,316,000. We also issued 6,409.45 shares of Series A preferred stock with total gross proceeds of $144,214 under the preferred stock DRIP, 878.30 shares of Series B preferred stock with total gross proceeds of $19,761 under the preferred stock DRIP, and 16.67 shares of Series C preferred stock with total gross proceeds of $375 under the preferred stock DRIP. All such issuances were pursuant to our Regulation A Series A, Series B and Series C preferred stock offering. In connection with the Regulation A preferred stock issuances described above, we paid broker-dealer fees of $242,572. The securities were sold to members of the general public who invested through our Regulation A offering.